473 filings
Page 9 of 24
4
CRNX
Crinetics Pharmaceuticals Inc
27 Jan 23
Crinetics Pharmaceuticals / Stephen F. Betz ownership change
4:26pm
4
Stephen F. Betz
19 Jan 23
Crinetics Pharmaceuticals / Stephen F. Betz ownership change
4:28pm
CORRESP
CRNX
Crinetics Pharmaceuticals Inc
19 Jan 23
Correspondence with SEC
12:00am
8-K
CRNX
Crinetics Pharmaceuticals Inc
9 Jan 23
Regulation FD Disclosure
8:43am
4
Stephen F. Betz
5 Jan 23
Crinetics Pharmaceuticals / Stephen F. Betz ownership change
4:23pm
UPLOAD
CRNX
Crinetics Pharmaceuticals Inc
20 Dec 22
Letter from SEC
12:00am
4
Stephen F. Betz
19 Dec 22
Crinetics Pharmaceuticals / Stephen F. Betz ownership change
5:11pm
4
CRNX
Crinetics Pharmaceuticals Inc
5 Dec 22
Crinetics Pharmaceuticals / Stephen F. Betz ownership change
5:28pm
8-K
CRNX
Crinetics Pharmaceuticals Inc
28 Nov 22
Crinetics Pharmaceuticals Provides Update on CRN04777 Program
8:32am
4
Stephen F. Betz
17 Nov 22
Crinetics Pharmaceuticals / Stephen F. Betz ownership change
4:46pm
S-8
CRNX
Crinetics Pharmaceuticals Inc
14 Nov 22
Registration of securities for employees
8:48am
10-Q
2022 Q3
CRNX
Crinetics Pharmaceuticals Inc
Quarterly report
14 Nov 22
8:31am
8-K
CRNX
Crinetics Pharmaceuticals Inc
14 Nov 22
Crinetics Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
8:15am
4
CRNX
Crinetics Pharmaceuticals Inc
3 Nov 22
Crinetics Pharmaceuticals / Stephen F. Betz ownership change
4:35pm
4
CRNX
Crinetics Pharmaceuticals Inc
19 Oct 22
Crinetics Pharmaceuticals / Stephen F. Betz ownership change
5:34pm
4
CRNX
Crinetics Pharmaceuticals Inc
14 Oct 22
Crinetics Pharmaceuticals / Richard Scott Struthers ownership change
4:55pm
8-K
CRNX
Crinetics Pharmaceuticals Inc
13 Oct 22
Enrollment Completed in Phase 3 PATHFNDR-1 Study Evaluating Oral Paltusotine for the Treatment of Acromegaly
8:32am
4
CRNX
Crinetics Pharmaceuticals Inc
11 Oct 22
Crinetics Pharmaceuticals / Dana Pizzuti ownership change
4:35pm
3
CRNX
Crinetics Pharmaceuticals Inc
11 Oct 22
Crinetics Pharmaceuticals / Dana Pizzuti ownership change
4:30pm
4
Stephen F. Betz
5 Oct 22
Crinetics Pharmaceuticals / Stephen F. Betz ownership change
4:40pm